145. the Efficacy and Safety of Low Dose Trimethoprim-sulfamethoxazole for the Treatment of Pneumocystis Pneumonia: A Systematic Review and Meta-analysis

BACKGROUND: Pneumocystis jirovecii pneumonia (PJP) is an opportunistic fungal infection causing significant morbidity and mortality in immunocompromised patients. The conventional treatment of PJP is sulfamethoxazole-trimethoprim (SMX-TMP) dosed at 15–20 mg/kg/day of the trimethoprim component. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Tritle, Brandon, Hejazi, Andre A, Timbrook, Tristan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778257/
http://dx.doi.org/10.1093/ofid/ofaa439.455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778257/
http://dx.doi.org/10.1093/ofid/ofaa439.455

Ejemplares similares